This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Juno Therapeutics Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jenna Bailey - Innovator in Antibody Research
Introduction
Jenna Bailey is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and chimeric antigen receptors.
Latest Patents
Jenna holds a patent for "Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)." This patent includes receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, specifically human antibodies that target ROR1, including antibody fragments. The patent also covers recombinant receptors, such as chimeric antigen receptors (CARs) that incorporate these antibodies or fragments, along with polynucleotides encoding the antibodies, antigen-binding fragments, or receptors specific for ROR1. Furthermore, it discusses genetically engineered cells containing ROR1-binding proteins and receptors, along with related methods and applications in adoptive cell therapy.
Career Highlights
Jenna is currently associated with Juno Therapeutics GmbH, where she continues her innovative work in antibody research. Her expertise in this area has positioned her as a key player in the advancement of therapeutic solutions.
Collaborations
Jenna collaborates with talented individuals such as Samriti Bedi and Andreia Costa, contributing to a dynamic research environment.
Conclusion
Jenna Bailey's work in antibody research and her innovative patent on ROR1-targeting molecules highlight her significant impact in the field of biotechnology. Her contributions are paving the way for advancements in adoptive cell therapy and related applications.